SARAH COLON: Open Payments
NPI 1437746559 · MANSFIELD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,002 in 52 payments from 14 companies in 2025. Trend: 2023 $260 · 2024 $302 · 2025 $1,002
Food & beverage: $1,002
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $223 |
| ABBVIE INC. | 18 | $215 |
| Corcept Therapeutics | 7 | $141 |
| Novo Nordisk Inc | 1 | $95 |
| Braeburn Inc. | 1 | $67 |
| Indivior Inc. | 3 | $63 |
| Lilly USA, LLC | 3 | $49 |
| Gilead Sciences, Inc. | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| ViiV Healthcare Company | 1 | $17 |
Products named: CAPLYTA, Korlym, VRAYLAR, Wegovy, BRIXADI, SUBLOCADE, QULIPTA, MOUNJARO.
Industry payments across OH — which companies pay providers there.
